Evidence map›Paper›PMID 39605722›Full record

ArticlebioRxiv : the preprint server for biology2024

ATR safeguards replication forks against APOBEC3B-induced toxic PARP1 trapping.

Pedro Ortega, Elodie Bournique, Junyi Li, Ambrocio Sanchez, Gisselle Santiago, Brooke R Harris, Abby M Green, Rémi Buisson

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Pedro OrtegaDepartment of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, USA.ORCID 0000-0003-4216-3695
Elodie BourniqueDepartment of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, USA.ORCID 0000-0003-0196-7996
Junyi LiDepartment of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, USA.
Ambrocio SanchezDepartment of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, USA.
Gisselle SantiagoDepartment of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, USA.
Brooke R HarrisDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
Abby M GreenDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-6436-2217
Rémi BuissonDepartment of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, USA.ORCID 0000-0002-7196-8209

Funding

Dignity Therapy RCT led by Nurses or Chaplains for Elderly Cancer OutpatientsR01CA200867 · NCI · UNIVERSITY OF FLORIDA · PI EMANUEL, LINDA LEAH, FITCHETT, GEORGE · 2016 to 2020
$3.2M
Molecular Mechanisms of APOBEC-Induced Mutagenesis in CancerR37CA252081 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Remi Buisson · 2021 to 2026
$2.5M
NCI NIH HHS R01 CA200867NCI NIH HHS R37 CA252081
6 · The paper itself

Abstract

ATR is the master safeguard of genomic integrity during DNA replication. Acute inhibition of ATR with ATR inhibitor (ATRi) triggers a surge in origin firing, leading to increased levels of single-stranded DNA (ssDNA) that rapidly deplete all available RPA. This leaves ssDNA unprotected and susceptible to breakage, a phenomenon known as replication catastrophe. However, the mechanism by which unprotected ssDNA breaks remains unclear. Here, we reveal that APOBEC3B is the key enzyme targeting unprotected ssDNA at replication forks, triggering a reaction cascade that induces fork collapse and PARP1 hyperactivation. Mechanistically, we demonstrate that uracils generated by APOBEC3B at replication forks are removed by UNG2, creating abasic sites that are subsequently cleaved by APE1 endonuclease. Moreover, we demonstrate that APE1-mediated DNA cleavage is the critical enzymatic step for PARP1 trapping and hyperactivation in cells, regardless of how abasic sites are generated on DNA. Finally, we show that APOBEC3B-induced toxic PARP1 trapping in response to ATRi drives cell sensitivity to ATR inhibition, creating to a context of synthetic lethality when combined with PARP inhibitors. Together, these findings reveal the mechanisms that cause replication forks to break during replication catastrophe and explain why ATRi-treated cells are particularly sensitive to PARP inhibitors.

Identifiers

PMID39605722
PMCPMC11601322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.